Skip to main content
Livermore
Livermore
ZHEN

Vicus Capital

SEC CIK
0001544806
Latest filing
Aug 5, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Vicus Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
4,464
Value
$405.1K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ABT by Vicus Capital, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,464$405.1K<0.1%+28+0.6%AddedHolders
Q1 20264,436$455.5K<0.1%−479−9.7%ReducedHolders
Q4 20254,915$615.9K<0.1%−51−1.0%ReducedHolders
Q3 20254,966$665.2K0.1%+95+2.0%AddedHolders
Q2 20254,871$662.5K0.1%−9−0.2%ReducedHolders
Q1 20254,880$647.3K0.1%−148−2.9%ReducedHolders
Q4 20245,028$568.7K0.1%+9+0.2%AddedHolders
Q3 20245,019$572.2K0.1%−1,006−16.7%ReducedHolders
Q2 20246,025$626.1K0.1%+888+17.3%AddedHolders
Q1 20245,137$583.8K0.1%+837+19.5%AddedHolders
Q4 20234,300$473.3K<0.1%−767−15.1%ReducedHolders
Q3 20235,067$490.7K0.1%+783+18.3%AddedHolders
Q2 20234,284$467.0K<0.1%+27+0.6%AddedHolders
Q1 20234,257$431.1K<0.1%−264−5.8%ReducedHolders
Q4 20224,521$496.3K0.1%−71−1.5%ReducedHolders
Q3 20224,592$444.0K0.1%+15+0.3%AddedHolders
Q2 20224,577$497.0K0.1%−367−7.4%ReducedHolders
Q1 20224,944$585.0K0.1%+761+18.2%AddedHolders
Q4 20214,183$538.0K0.1%+4,183NewHolders
Q2 20210$00.0%−3,262−100.0%Sold outHolders
Q1 20213,262$391.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.